Figure 1
Figure 1. MALDI-TOF MS of purified human leukocyte monosialoglycosphingolipids. The monosialo GSL fraction from human leukocytes was subjected to MALDI-TOF MS. Peaks corresponding to masses of glycosphingolipids 110 mass units separated, reflecting the presence of the same glycan species bearing either C16:0 or C24:1 fatty acid amides, are indicated. The proposed structures are abbreviated as n/m where n is the number of LacNAc repeats and m the number of fucoses in the general structure NeuAcα2-3[Galβ1-4(Fucα1-3)0-1GlcNAcβ1-3]nGalβ1-4GlcβCer. The inset structure, 3/1, was isolated from human leukemia cells and contains 3 LacNAc repeats (one of which is fucosylated) and the VIM-2 structure19 (International Union of Pure and Applied Chemistry [IUPAC, Research Triangle Park, NC] designation: VIII3NeuAcV3Fuc-nLc8Cer).

MALDI-TOF MS of purified human leukocyte monosialoglycosphingolipids. The monosialo GSL fraction from human leukocytes was subjected to MALDI-TOF MS. Peaks corresponding to masses of glycosphingolipids 110 mass units separated, reflecting the presence of the same glycan species bearing either C16:0 or C24:1 fatty acid amides, are indicated. The proposed structures are abbreviated as n/m where n is the number of LacNAc repeats and m the number of fucoses in the general structure NeuAcα2-3[Galβ1-4(Fucα1-3)0-1GlcNAcβ1-3]nGalβ1-4GlcβCer. The inset structure, 3/1, was isolated from human leukemia cells and contains 3 LacNAc repeats (one of which is fucosylated) and the VIM-2 structure19  (International Union of Pure and Applied Chemistry [IUPAC, Research Triangle Park, NC] designation: VIII3NeuAcV3Fuc-nLc8Cer).

Close Modal

or Create an Account

Close Modal
Close Modal